NCT01693159

Effects of ECA on Quality of Life in Head and Neck Cancer Patients Suffering From Cetuximab-induced Rhagades

Randomized Controlled Multicenter Trial to Evaluate the Effects of Ethyl-2-cyanoacrylate on Pain Intensity and Quality of Life in Head and Neck Cancer Patients Suffering From Cetuximab-induced Rhagades During Radioimmunotherapy

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 50 (estimated)
• Sponsor: National Center for Tumor Diseases, Heidelberg · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The SUPPORT trial is an open-label, prospective, randomized, national multicenter intervention study to evaluate the effectiveness of ethyl-2-cyanoacrylate versus the standard treatment of each institution on the pain intensity and QoL in patients with locally advanced head and neck cancer suffering from painful cetuximab-induced rhagades during radioimmunotherapy.

Conditions

• Pain

Interventions

Type	Name	Description
DEVICE	ECA	In the experimental arm patients will be topically treated with the liquid glue ethyl-2-cyanoacrylate (ECA).
OTHER	Standard topical treatment of the institution, e.g. Lotio	Standard treatment of the institution to treat painful cetuximab-induced rhagades

Timeline

• Start date: 2011-05-01
• Primary completion: 2018-07-01
• Completion: 2018-11-01
• First posted: 2012-09-26
• Last updated: 2017-09-25

Locations

1 site across 1 country: Germany